British Society for Antimicrobial Chemotherapy

Recent papers from British Society for Antimicrobial Chemotherapy

1. A Pragmatic Approach to Investigating Nosocomial Acquisition of Rare and Emerging MoldsMedical Mycology · 2026
2. A Duty to ActOpen Forum Infectious Diseases · 2026
3. A Duty to ActThe Journal of Infectious Diseases · 2026
4. Antimicrobial effectiveness within a new paradigm of infrastructureThe Journal of Law Medicine & Ethics · 2026
5. Multipronged Cell Wall-Targeting Converts Ineffective Antibiotics into a Potent Regimen against Mycobacterium abscessusACS Infectious Diseases · 2026
6. Optimizing intravenous amoxicillin for outpatient parenteral antimicrobial therapyJAC-Antimicrobial Resistance · 2026
7. Beyond Histone Demethylation: Mechanisms of N -Alkyl Consecutive Oxidations by the Non-Heme Fe(II)/2-Oxoglutarate Oxygenase KDM6BJACS Au · 2026
8. Addressing the dual-use of antifungals and fungal antimicrobial resistance (fAMR) through a One Health approachnpj Antimicrobials and Resistance · 2026
9. Challenges and drivers in the implementation of current practices in outpatient parenteral antimicrobial therapy: an international survey.2026
10. Nosocomial outbreaks with rare yeasts: trends, characteristics and preventive measuresJournal of Infection · 2026
11. The redox-active CXXC motif of BCAT1 regulates extracellular vesicle biogenesis in U937 macrophagesExperimental Cell Research · 2026
12. UK Antimicrobial Registry: Virtual Registry-an innovative surveillance approach for monitoring the real-world use and effectiveness of newly licensed antimicrobials in ScotlandJAC-Antimicrobial Resistance · 2026
13. Development of a capability framework for antimicrobial stewardship specialist health professionals working in the NHS in England: utilizing Delphi methodologyJournal of Antimicrobial Chemotherapy · 2025
14. Disarming carbapenemase-producing Acinetobacter baumannii : high potency of the novel therapeutic combination of meropenem and the innovative diazabicyclooctane β-lactamase inhibitor pilabactam (formerly ANT3310)Antimicrobial Agents and Chemotherapy · 2026
15. Exploring the perspectives of antimicrobial stewardship pharmacists in England on the subscription model for antimicrobial drugsJAC-Antimicrobial Resistance · 2026
16. A systematic review of antimicrobial stewardship education for undergraduate students in medicine, nursing, pharmacy, dentistry, veterinary science and midwifery using COM-B frameworkJAC-Antimicrobial Resistance · 2025
17. The UK Antimicrobial Registry (UKAR): an overview of the first 20 months of recruitmentJAC-Antimicrobial Resistance · 2025
18. Successful outpatient parenteral antimicrobial therapy with rezafungin for chronic pulmonary aspergillosis: a case report and health economic assessmentJAC-Antimicrobial Resistance · 2025
19. Applications and benefits of the British Society for Antimicrobial Chemotherapy Resistance Surveillance Project—legacy and futureJournal of Antimicrobial Chemotherapy · 2025
20. Establishing the pivotal role of infectious diseases and clinical microbiology professional societies; a global surveyJournal of Global Antimicrobial Resistance · 2025